228 related articles for article (PubMed ID: 23839233)
1. DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11.
James SR; Cedeno CD; Sharma A; Zhang W; Mohler JL; Odunsi K; Wilson EM; Karpf AR
Epigenetics; 2013 Aug; 8(8):849-63. PubMed ID: 23839233
[TBL] [Abstract][Full Text] [Related]
2. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
Estève PO; Chin HG; Pradhan S
J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
[TBL] [Abstract][Full Text] [Related]
4. PRAME expression and promoter hypomethylation in epithelial ovarian cancer.
Zhang W; Barger CJ; Eng KH; Klinkebiel D; Link PA; Omilian A; Bshara W; Odunsi K; Karpf AR
Oncotarget; 2016 Jul; 7(29):45352-45369. PubMed ID: 27322684
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation determines nucleosome occupancy in the 5'-CpG islands of tumor suppressor genes.
Portela A; Liz J; Nogales V; Setién F; Villanueva A; Esteller M
Oncogene; 2013 Nov; 32(47):5421-8. PubMed ID: 23686312
[TBL] [Abstract][Full Text] [Related]
6. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
Milutinovic S; Brown SE; Zhuang Q; Szyf M
J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
[TBL] [Abstract][Full Text] [Related]
7. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.
Woloszynska-Read A; Zhang W; Yu J; Link PA; Mhawech-Fauceglia P; Collamat G; Akers SN; Ostler KR; Godley LA; Odunsi K; Karpf AR
Clin Cancer Res; 2011 Apr; 17(8):2170-80. PubMed ID: 21296871
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.
Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P
BMC Cancer; 2013 Mar; 13():156. PubMed ID: 23530769
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Taverna P; Karpf AR; Griffiths EA
Epigenetics; 2015; 10(3):237-46. PubMed ID: 25793777
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction between co-expressed MAGE-A proteins.
Laiseca JE; Ladelfa MF; Cotignola J; Peche LY; Pascucci FA; Castaño BA; Galigniana MD; Schneider C; Monte M
PLoS One; 2017; 12(5):e0178370. PubMed ID: 28542476
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer.
Woloszynska-Read A; James SR; Link PA; Yu J; Odunsi K; Karpf AR
Cancer Immun; 2007 Dec; 7():21. PubMed ID: 18095639
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.
Karpf AR; Bai S; James SR; Mohler JL; Wilson EM
Mol Cancer Res; 2009 Apr; 7(4):523-35. PubMed ID: 19372581
[TBL] [Abstract][Full Text] [Related]
13. BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines.
Woloszynska-Read A; James SR; Song C; Jin B; Odunsi K; Karpf AR
Cancer Immun; 2010 Jul; 10():6. PubMed ID: 20649179
[TBL] [Abstract][Full Text] [Related]
14. Altered promoter nucleosome positioning is an early event in gene silencing.
Hesson LB; Sloane MA; Wong JW; Nunez AC; Srivastava S; Ng B; Hawkins NJ; Bourke MJ; Ward RL
Epigenetics; 2014 Oct; 9(10):1422-30. PubMed ID: 25437056
[TBL] [Abstract][Full Text] [Related]
15. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic activation of POTE genes in ovarian cancer.
Sharma A; Albahrani M; Zhang W; Kufel CN; James SR; Odunsi K; Klinkebiel D; Karpf AR
Epigenetics; 2019 Feb; 14(2):185-197. PubMed ID: 30764732
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells.
Link PA; Gangisetty O; James SR; Woloszynska-Read A; Tachibana M; Shinkai Y; Karpf AR
Mol Cancer Res; 2009 Jun; 7(6):851-62. PubMed ID: 19531572
[TBL] [Abstract][Full Text] [Related]
18. BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer.
Link PA; Zhang W; Odunsi K; Karpf AR
Cancer Immun; 2013; 13():6. PubMed ID: 23390377
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.
Han H; Cortez CC; Yang X; Nichols PW; Jones PA; Liang G
Hum Mol Genet; 2011 Nov; 20(22):4299-310. PubMed ID: 21835883
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases.
Vincent A; Ducourouble MP; Van Seuningen I
FASEB J; 2008 Aug; 22(8):3035-45. PubMed ID: 18492726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]